Recalls & Warnings
ConsumerLab.com is keeping you informed with current product recalls and warnings.
Posted February 24, 2011
Recall of Counterfeit Extenze Tablets Containing Drugs
On February 23, 2011, the FDA announced that Biotab Nutraceuticals, Inc. was notified that two lots of counterfeit product purporting to be Extenze contain undeclared drug ingredients. Specifically, lot 0709241 contains tadalafil and sildenafil, and lot 0509075 contains tadalafil and sibutramine.